Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT. (2021)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3310/hta25260
PubMed Identifier: 33928903
Publication URI: http://europepmc.org/abstract/MED/33928903
Type: Journal Article/Review
Volume: 25
Parent Publication: Health technology assessment (Winchester, England)
Issue: 26
ISSN: 1366-5278